Castle Biosciences Inc

NASDAQ:CSTL  
55.27
+5.20 (+10.38%)
Other Pre-Announcement, Mergers / Acquisitions

Castle Biosciences To Acquire Myriad myPath Laboratory In $32.5 Mln Deal

Published: 04/27/2021 11:58 GMT
Castle Biosciences Inc (CSTL) - Castle Biosciences Signs Definitive Agreement to Acquire Myriad Mypath® Laboratory.
Castle Biosciences Signs Definitive Agreement to Acquire Myriad Mypath® Laboratory.
Castle Biosciences Inc - Castle is Acquiring Myriad Mypath Laboratory for $32.5 Million.
Castle Biosciences Inc - Will Finance Acquisition Price With Cash and Cash Equivalents on Hand.
Castle Biosciences - Upon Completion, Castle Will Be Successor Owner of Myriad Mypath Laboratory.
Castle Biosciences - Co Expects to Make Available Most Comprehensive Molecular Testing Offering for Difficult-to-diagnose Melanocytic Lesions.